Nvidia: Analysts Anticipate $5.8 Billion In Q3 Revenues

Nvidia Corp (NASDAQ: NVDA) will be reporting their fiscal third quarter financial results May 26th after market close. Analysts have a consensus $669.16 12-month price target on the company, via a total of 41 analysts, with ten analysts having strong buy ratings, 24 analysts having buy ratings, six have hold ratings and one analyst has a sell rating. The street high comes is a $800 price target from Needham, and the lowest target sits at $380 from BNP Paribas.

29 analysts have revenue estimates for the third quarter. The mean revenue estimate between all 29 analysts is $5.8 billion; this number has been revised upwards from $5.27 billion at the start of the year. The highest revenue estimate is $6.243 billion, while the lowest is $5 billion.

The analyst consensus for net income for the third quarter is $2.227 billion, this is up from the start of the year at $2 billion. The highest net income estimate is $2.489 billion, while the lowest is $1.833 billion.

Onto EBITDA estimates, there are currently only 5 analysts who have third quarter EBITDA estimates. The mean is currently $2.771 billion, with this number having been revised higher from $2.458 billion at the start of the year. The street high estimate currently sits at $2.898 billion in EBITDA and the lowest is $2.526 billion.

Analysts estimate that quarterly earnings per share will come in at $3.53, with this number being higher from the $3.15 estimate at the start of the year. The street high is $3.95 and the lowest estimate is $2.90 per share for the quarter.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

This Gold Discovery Just Keeps Getting Bigger | Roger Rosmus – Goliath Resources

8 Mining Stocks Our Viewers Asked Us to Review | Sept 14th-18th

Canada Is Finally Fast-Tracking New Mines | John Passalacqua – First Phosphate

Recommended

This Gold Discovery Just Keeps Getting Bigger | Roger Rosmus – Goliath Resources

Cardiol Expands MAVERIC Trial to Up to 150 Patients After Reaching Enrollment Target Early

Related News

WeCommerce: TD, Canaccord Raise Price Targets After Leading Bought Deal

Last week, WeCommerce (TSXV: WE) announced that their bought deal closed. The company issued 2.81...

Friday, July 16, 2021, 04:09:00 PM

Kinross Gold: Analysts Drop Targets Following Mill Fire

On June 21st, Kinross Gold Corporation (TSX: K) announced an update on the Tasiast Mill...

Thursday, June 24, 2021, 10:54:00 AM

Cresco Labs: Stifel Slashes Price Target From $30 To $8 Following Poor Q4 Results

On March 23rd, Cresco Labs (CSE: CL) announced its fourth-quarter financial results, which disappointed many...

Friday, March 25, 2022, 03:39:00 PM

PopReach Receives Upgraded Price Target from Canaccord Amid $5M Investment from Alibaba Investment Arm

On Thursday, PopReach (TSXV: POPR) announced a $5.0 million investment from eWTP Tech Innovation Fund...

Sunday, October 18, 2020, 12:48:00 PM

Kirkland Lake Gold: Analysts Reiterate Targets Following Financing Results

Last week, Kirkland Lake Gold (TSX: KL) announced their fourth quarter and full year 2021...

Wednesday, March 3, 2021, 02:50:00 PM